Remus Pharmaceuticals Ltd
Remus Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Remus Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Remus Pharmaceuticals Ltd Share Price Chart
Remus Pharmaceuticals Ltd Fundamentals
Traded Volume: 2,400
Market Cap(Cr): 819
Avg Traded Price 698.89
1 Year return -40.60%
Upper Circuit 725
Lower Circuit 680
P/E TTM 28.00
P/B Ratio 25.00
Traded Value(Cr) 16.68
EPS TTM 24.669
Book value 24.669
Dividend 0.00%
Remus Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Remus Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Remus Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -9.05%
1M +2.22%
3M -26.04%
1Y -40.60%
YTD -41.47%
Remus Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Remus Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 4800.00
Day Before Yesterday 1900.00
1W Avg 3280.00
1M Avg 4485.00
3M Avg 4313.11
Remus Pharmaceuticals Ltd Technical Details
Remus Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 675
Support 2 655
Support 3 630
Pivot Point : 700
Resistance 1 720
Resistance 2 745
Resistance 3 765
Remus Pharmaceuticals Ltd Corporate Actions
Remus Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Remus Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 14-Nov-2025 Type D Description 0.50/share@5.00% Record Date 14-Nov-2025 Ratio 5.00
Ex-Date 18-Sep-2025 Type D Description 0.50/share@5.00% Record Date 18-Sep-2025 Ratio 5.00
Ex-Date 04-Jul-2025 Type B Description share@1:1 Record Date 04-Jul-2025 Ratio 1:1
Ex-Date 19-Nov-2024 Type D Description 1.00/share@10.00% Record Date 20-Nov-2024 Ratio 10.00
Ex-Date 06-Jun-2024 Type B Description share@3:1 Record Date 06-Jun-2024 Ratio 3:1
Ex-Date 02-May-2024 Type D Description 4.00/share@40.00% Record Date 02-May-2024 Ratio 40.00
Ex-Date 27-Oct-2023 Type D Description 2.00/share@20.00% Record Date 28-Oct-2023 Ratio 20.00
Ex-Date 15-Sep-2023 Type D Description 2.00/share@20.00% Record Date 15-Sep-2023 Ratio 20.00
Dividends
Announcement Date 14-Nov-2025 Ex Dividend Date 14-Nov-2025 Dividend(%) 5
Announcement Date 18-Sep-2025 Ex Dividend Date 18-Sep-2025 Dividend(%) 5
Announcement Date 19-Nov-2024 Ex Dividend Date 19-Nov-2024 Dividend(%) 10
Announcement Date 02-May-2024 Ex Dividend Date 02-May-2024 Dividend(%) 40
Announcement Date 27-Oct-2023 Ex Dividend Date 27-Oct-2023 Dividend(%) 20
Announcement Date 15-Sep-2023 Ex Dividend Date 15-Sep-2023 Dividend(%) 20
Bonus
Record Date 04-Jul-2025 Ex-Bonus Date 04-Jul-2025 Ratio 1:1
Record Date 06-Jun-2024 Ex-Bonus Date 06-Jun-2024 Ratio 3:1
Splits
No Split has been declared by REMUS
Others
Rights No Rights has been declared by REMUS
Remus Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Remus Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Remus Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Remus Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Remus Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 15.59 Mar 2024 2.43 Mar 2023 5.31 Mar 2022 5.04 Mar 2021 2.84
PARTICULARS Investing Activities Mar 2025 -12.42 Mar 2024 -20.90 Mar 2023 -15.19 Mar 2022 -4.55 Mar 2021 -3.09
PARTICULARS Financing Activities Mar 2025 -1.42 Mar 2024 39.29 Mar 2023 11.77 Mar 2022 -0.17 Mar 2021 -0.12
PARTICULARS Net Cash Flow Mar 2025 1.75 Mar 2024 20.81 Mar 2023 1.89 Mar 2022 0.32 Mar 2021 -0.37
Remus Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Remus Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 70.91%
Public 23.3%
Other Institutions 0.77%
FII 5.02%
Mutual Funds null%
About Remus Pharmaceuticals Ltd
Remus Pharmaceuticals Limited was originally incorporated as `Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat. Subsequently, Company converted from a Private to Public and the name of the Company was changed to Remus Pharmaceuticals Limited on January 06, 2023 by the Registrar of Companies, Ahmedabad.The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs. It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries. The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet. The core business of the Company into three categories, which comprise of Manufacturing, through loan licencse or on contract manufacturing bassis, of approved finished formulations and distribution of the same in various countries; Trading of Active Pharmaceutical Ingredients and Technical Consultancy on preparation of reports on pharmaceutical dossiers.The product portfolio comprises of therapeutic drugs like ACE inhibitors, anaesthetic, Anti histamine, Antifungal, Anti-inflammatory, Antibiotic, Antidiabetic, Antipsychotic, Antiretroviral, Chronic Obstructive Pulmonary Disease, Asthma, Carcinoid tumours, CNS stimulants, Nasal decongestants, Potassium deficiency, Probiotic, Antispasmodic, Ocular-hypertension, Urology and Vitamin deficiency. The Pharma business operations are supported by various contract manufacturers having facilities which are WHO GMP Compliant. The core strength lies in getting approved formulation manufactured through contract manufacturers under loan licence and marketing of formulations through marketing network across geographies.The Company incorporated 'Relius Pharmaceuticals SRL' as a new subsidiary Company in Bolivia, effective on October 13, 2023. The Company made an Initial Public Issue of 388000 Equity Shares of face value of Rs 10/- each by raising funds aggregating to Rs 47.68 Crore through Fresh Issue in May, 2023.The Company acquired a stake of 56.67% in Espee Global Holdings LLC, making it a subsidiary of the Company effective on January 1, 2024. The Company expanded the operational footprint to over 40 countries with Latin America in FY 2025. It strengthened presence in Bolivia by launching 10+ products via 8 pharmacy chains, 10 hospitals, and 3 sub-distributors in 2025.
null
null
Registered office 1101 to 1103 South Tower One42, B/H Ashok Vatika Amblibopal Rd, Ahmedabad, Gujarat, 380054
FAX :91-079-29999857
Background
Incorporation Year 2015
Face Value ₹10.00
Market Lot 100
FAQs on Remus Pharmaceuticals Ltd
How to buy Remus Pharmaceuticals Ltd shares on NSE?
To buy Remus Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Remus Pharmaceuticals Ltd share price today?
The Remus Pharmaceuticals Ltd share price on NSE is ₹695.05 today.
What is the market cap of Remus Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹819.05.
What is the PE & PB ratio of Remus Pharmaceuticals Ltd?
PE is 28 and PB is 25.
What is the 52 Week High and Low of Remus Pharmaceuticals Ltd shares?
Remus Pharmaceuticals Ltd stock price high: ₹1385 Remus Pharmaceuticals Ltd stock price low: ₹630.